IL17A and skin disorder: In addition, IL-23 promoted the expression of IL-17A, IL-17F, IFN-γ, and IL-22 in M0 macrophages, and IL-23-treated M0 macrophages significantly enhanced psoriasis-like dermatitis in the mouse model [17].